Saratov JOURNAL of Medical and Scientific Research

The microecological and immunological problems of persistention of Helicobacter pylori

Year: 2016, volume 12 Issue: №1 Pages: 19-26
Heading: Microbiology Article type: Review
Authors: Belova O.L., Schelekhova T.V., Belova I.M.
Organization: Saratov State Medical University
Summary:

The interrelation of persistence of Helicobacter pylori in stomach with innate and adaptive immunity of human has been discussed. The analysis of the mechanisms of immunological recognition of the antigens of this microorganism and response to them has been performed. It has been considered, that the development and course of gastritis and ulcer in human with Helicobacter pylori stipulate for inadequate reactions of immune system and common reactivity by the individual organism in presence of Helicobacter pylori in mucus of stomach.

Bibliography:
1. Malferheiner P., Selgrad M. Helicobacter pylori infection and current clinical areas of contention. Curr Opin Gastroenterol 2010; 26 (6): 618-623
2. Jebrun AB. Infection of the Helicobacter pylori. Sanct-Petersburg, 2006; 380 p.
3. Zhimmerman JS. Gastroduodenal diseases and Helicobacter pylori infection: general review of problem. Clinical medicine 2009; 5: 9-14
4. Maev I, Samsonov АА, Andreev NG, et al. Important practical results and modern tendency in treatments of diseases stomach and duodenum. Russian Journal of Gastroenterology Hepatology and Coloproctology 2012; 4: 17-26
5. Isakov VA, Domoradskii IV. Helicobacteriosis. М., 2003; 412 p.
6. Costa AC, Figueiro С, Tonati Е. Pathogenesis of Helicobacter pylori infection. Helicobacter 2009; 14 (Suppl): 15-20
7. Chiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in Helicobacter pylori. J Dig Dis 2013; 14 (7): 341-349
8. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Natl Rev Gastroenterol Hepatol 2010; 7 (11): 629-641
9. Kusters JG, Amoud HM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19 (3): 449-490
10. Salama Nr, Hartung Ml, Muller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Natl Rev Microbiol 2013; 11 (6): 385-399
11. Yadegar A, Mobarez FV, Alebouyeh M, et al. Clinical relevance of cagL gene and virulence genotypes with disease outcomes in Helicobacter pylori infected population from Iran. World J Gastroenterol 2014; 30 (9): 2481-2490
12. Almeida N, Donato MM, Romeorinho JM, et al. Correlation of Helicobacter pylori genotypes with gastric histopathology in the central region of a South-European country. Dig Dis Science 2015; 60 (1):74-85
13. Hemmatinezhad B, Memtaz H, Rahimi E. VacA, cagA, iceA and oipA genotypes status and antimicrobial resistance properties of Helicobacter pylori isolated from various types of ready to eat foods. Annal Microbiol Antimicrobials 2016; 15 (2): 251-260
14. Fehling M, Drobbe L, Moos V, et al. Comparative analysis of the interaction of Helicobacter pylori with human dendridic cells, macrophages, and monocytes. Infect Immun 2012; 80 (8): 2724-2734
15. Basso D, Zambon CF, Letleg DP. Clinical relevance of Helicobacter pylori cagA and vacA gene polimorphism. Gastroenterology 2008; 135: 91-99
16. Bik EM. Molecular analysis of the bacterial microbiota in the stomach. Proc Natl Acad Sci USA 2006; 103: 732-737
17. Dicksved J, Lindberg M, Rosenquist M, et al. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 2009; 58: 509-516
18. Chernin VV, Bondarenko VM, Chervonec VM, et al. The seat of Helicobacter pylori in normobiocenosis and disbacteriosis of mucosal microflora of the ezophagogastroduodenal zone in his inflammatorily erosion-ulcer defeats. Therapeutic Archive 2012; 84 (2): 10-16
19. Zhimmerman JS, Zaharova JuA, Vedernikov VE. Microflora of mucous membrane of the stomach, his property and role in progress acute and chronical gastritis. Clinical Medicine. 2012; 90 (11): 39-44
20. Yang I, Nell S, Suerbaum S. Survival in hostile territory: the microbiota of the stomach FEMS. Microbiol 2013; 37 (5): 736-761
21. Cloud ML, Enas N, Humphries TJ, Bassion S. The Rabeprasole Study Group. Rabeprasole in treatment of acid peptic diseases: result of three placebo-controlled dose response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). Dig Dis Sci 1998; 43: 993-1000
22. Krylov NN. The problems that non can be agitated: Utopias and realities of modern teaching about of ulcer disease. Herald Surgery Gastroenterology 2007; 1: 25-30
23. Grinevich VB, Lysyj VP, Abromjan LL, et al. The peculiarity ulcer disease with non- connected with Helicobacter pylori. Therapeutic Archive 2002; 2: 24-27
24. Butov MA. About ethyology and pathogenesis ulcer disease Experimental Clinical Gastroenterology 2003; 5: 5-9
25. Zhimmerman JS. Undeceive and disputable problems of modern gastroenterology M.: Medpress-info, 2013; 224 p.
26. Amelchugova OS, Tretjakova OV, Vasjutin AV, et al. Lowering widespread ulcer disease in Russia? Russian Journal Gastroenterology, Hepatology and Coloproctology 2014; 24 (5): 15
27. Owen R,Xerry J, GotadaT, etal. Analysis of geospecific markers for Helicobacter pylori variants in patients from Japan and Nigeria by triple-locus nucleotide sequence typing. Microbiol 2004; 150: 151-161
28. Ly Yeh, Kaj M, Hassan S, et al. Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori. Indian J Gastroenterol 2009; 28 (2): 49-52
29. Chen S, Ying L. Kong M, et al. The prevalence of Helicobacter pylori infection decreases with older age in atrophic gastritis. Gastroenterol Res Pract 2013; 2013: 494-505
30. Lazebnik LB, Vasiliev JuV, Shherbakov PL, et al. Helikobakter pilori: widespread, diagnosis, threatment. Experimental Clinical Gastroenterology 2010; 2: 3-7
31. Chervonec VM, Bazlov SN, Chernin VV. Microflora of periulceral zona in patients witch ulcer disease and his perceptibility for antibacterial preparations Experimental Clinical Gastroenterology 2002; 1: 37-39
32. Chernin VV Diseases of the esophagus, stomach and duodenum. Moscow: MIA, 2010; 528 p.
33. Take S, Mizuno М, Ishiki К, et al. Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan. J Gastroenterol 2012; 47 (6): 641-646
34. Morgan D, Torres J, Sexton R, et al. Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA 2013; 309 (6): 578-586
35. Vaira D, Valik N. Blood, urine, stool, breath, money and Helicobacter pylori. Gut 2001 ;48 (3): 287-289
36. Hermanns W, Smith K, Breuer W, et al. Helicobacter-like organisms: histopathological examination of gastric biopsies from dogs and cats. J Comparative Pathol 1995; 112 (2): 307-318
37. Eslik GD. Helicobacter pylori infection transmitted sexually via oral-genital contact: a hypothetical model. Sex Transmit Inf 2000; 76 (6): 489-492
38. Al Sayed A, Anand PS, Kamath KP, et al. Oral cavity as an extragastric reservoir of Helicobacter pylori. ISRN Gastroenterol 2014: 261-269
39. Solovjova IV, Belova IV, Tochilina AG, et al. Microbiological principles correction of «disbiosis» microflora of human. Medical Almanac 2013; 2: 60-65
40. Zaika GE, Postnikova El, Meshkov VA, et al. Frequency of discovery Helicobacter pylori in mucous membrane of stomach, with baby with syndrome of the vomit. Russian Journal of Gastroenterology, Hepatology and Coloproctology 2014; 24 (5): 20
41. Melnikova VA, Arzumanjan NO. Helicobacter pylori by the diseases of the gastric and intestines and in healthy human. Journal Microbiology, Epidemiology Infection 2001; 6: 108-112
42. Svarval A, Ferman RS, Zhebrun АВ. Analysis of prevalensity Helicobacter pylori among of children in modern period. Journal Microbiology, Epidemiology Infection 2012; 1: 83-88
43. Chung С, OlivaresA, Torres Е, et al. Diversity of VacA intermediate region amon Helicobacter pylori strains from several region of the World. J Clin Microbiol 2010; 48 (3): 690-696
44. Olbermann P, Josenhans Ch. A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet 2014; 10(1): 100-106
45. Blachard TG, Czinn SJ, Correa P, et al. Genome sequence of 65 Helicobacter pylori strains isolated from asymptomatic individuals and patients with gastric cancer, peptic ulcer disease, or gastritis. Pathol Dis2013; 18 (2): 39-43
46. Suzuki P, Shiota C, Yamaoka U. Molecular epidemiology, population genetics, and pathogenic role Helicobacter pylori Infect. Genet Evol Mar 2012; 12 (2): 203-213
47. Yamaoka Y. Pathogenesis of Helicobacter pylori-related gastroduodenal diseases from molecular epidemiological studies. Gastroenterol Res Pract 2012; 2012: 503-513
48. Talarico S, Whitefield SE, Fero J, et al. Regulation of Helicobacter pylori adherence by gene conversion. Mol Microbiol 2012; 84 (6): 1050-1061
49. Oertly M, Noben M, Engler DB, et al. Helicobacter pylori gamma-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance. Proc Natl Acad Sci USA 2013; 110 (8): 3041-3052
50. Romo-Gonzalez C, Salama N, Burgena-Ferreira J. Differences in genome content among Helicobacter pylori isolates from patients with gastritis, duodenal ulcer, or gastric cancer reveal novel disease-associated genes. Infect Immun 2009; 77: 2201-2211
51. Sucuro LK, Timna J, Wyckoff S. Multipl peptidoglycan modification network modulate Helicobacter pylori cells sgape, motility, and colonization potential. PloS Pathog 2012; 8 (3): 588-595
52. Dorer MS, Cohen IE, Sessler H, et al. Natural competence promotes Helicobacter pylori chronic infection. Infect Immun 2013; 81 (1): 209-215
53. Mamtaz H, Dabiri H, Souod N, Gholami M. Study of Helicobacter pylori genotype status in cows, sgeep, goats and human beings ВМС. Gastroenterol 2014;14:61-70
54. Mishra S. Is Helicobacter pylori good or bad? Eur J Clin Microbiol Infect Dis 2013; 32: 301-304
55. Mimoro H. Strategy of Helicobacter pylori to enhance colonization of the stomach Nikon Sakinqaku Zasshi 2009; 64 (2-4): 311-317
56. Rhee K-H, Park J-S, Cho M-J. Helicobacter pylori: bacterial strategy for incipient stage and persistent colonization in human gastric niches. Yoncei Med J 2014; 55 (6): 1453-1466
57. Jarilin AA. Immunology M.: Geotar-Media, 2010: 752 p.
58. Bukharin OV, Lobakov ES, Perunov NB, et al. Symbiosis and his role in infection. Ekaterinburg, 2011; 300 p.
59. Zemskov AM, Zemskov VM, Chereshnev VA, et al. Guidance by clinical immunology for practices doctor. M.: Triada-X, 2011; 288 p.
60. Haitov RM. Immunology: the structure and function of the immune system. M.: Geotar-Media, 2013; 277 p.
61. Ricci V, Romano М, Boquet P. Molecular cross-talk between Helicobacter pylori and human gastric mucosa. World J Gastroenterol 2011; 21 (11): 1383-1399
62. Philpott DJ, Sorbara MT, Robertson SJ, et al. NOD proteins: regulators of inflammation in health and disease. Natl Rev Immunol 2014; 14 (1): 9-23
63. Calamuro ACT, Rossi AGT, Manuezzo NM, Silva AE. Helicobacter pylori infection: host immune response, implication on gene expression and microRNAs. World J Gastroenterol 2014; 20 (8): 1429-1437
64. Pham KT, Fischer W Helicobacter pylori utilizes DNA shuffling to modulate the gastric inflammatory response. Future Microbiol 2013; 8 (7): 835-838
65. Kurilovich SA, Reshetnikov OV, Granberg S. Helicobacteriosis in some population of the Siberia. Russian Journal of Gastroenterology, Hepatology, and Coloproctology 1997; 5 (4): 223
66. Kuchtevich AV, Bolotova OV, Zilov RG. Current of ulcer disease in dependence from constitutional peculiarities of patients. Clinical Medicine 2001; 5: 41-44
67. Cukanov VV, Shtygasheva OV, Barkalov SB. Helicobacter pylori and ulcer disease in population of the Khakassia. Therapeutic Archive 1999; 71 (2): 17-19
68. Sorokin VM, Golubkina EV, Bereznjak EA, et al. Comparative analysis of VNTR-genotypes Helicobacter pylori in south Russia. Russian Journal of Gastroenterology, Hepatology, and Coloproctology 2014; 5: 116
69. Badmos KB, Os О, Olasode BJ, Arigbabu АО. Gastric precancerous lesions among Nigerians with chronic gastritis. Niger Postgrad Med J 2012; 19 (2): 92-96
70. Maran S, Lee YY, Xu S, et al. Gastric precancerous lesions are associated with gene variants in Helicobacter pylori-susceptible ethnic Malays. World J Gastroenterol 2013; 19 (3): 3615-3622
71. Correa RG, Milotinovic S, Reed JO Role of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases. Biosci Rep 2012; 32 (Pt6): 597-608
72. Ageeva ES, Iptyshev VM, Stygasheva OV, Rayasantseva NV. Ethnic and population-specific features of some immunological parameters in chronic Helicobacter pylori infection Med Immunol 2014; 24 (3): 249-254
73. Steinman RM. Decision about dendritic cells: past, present, and future. Ann Rev Immunol 2011; 30: 1-22
74. Freitas-Silva R, Brelaz-de-Castro MC, Pereira VR. Dendric cell-based approaches in the fight against diseases. Front Immunol 2014; 5: 78-86
75. Bondarenko VM, Lichoded VG. Discern of commensal microflora image-discerning receptors in physiology and pathology. Journal Microbiology, Epidemiology Infection 1012; 3: 82-89
76. Necchi V, Manca R, Ricci V, Solsia F. Evidence for transepithelial dendritic cells in human Helicobacter pylori active gastritis. Helicobacter 2009; 14 (3): 208-212
77. Red P, Ballhorm W, Voland P, et al. Extracellular and intracellular pattern recognition receptor in the recognition of Helicobacter pylori. Gastroenterology 2009; 136: 2247-2257
78. Shiu J, Blanchard TG. Dendritic cell function in the host response to Helicobacter pylori infection of the gastric mucosa. Pathol Dis 2013; 67 (1): 46-53
79. Ogumu S, Satoskar A. The emerging role of dendritic cells in the host response against Helicobacter pylori. Front Microbiol 2014; 5:560-564
80. Sayi A, Otani K. Toll-like receptor 9 signaling has anti-inflammatory effects on the early phase Helicobacter pylori-induced gastritis. Biochem Biohys Res Commun 2012; 426:342-349
81. Fritz JH, Le Bourhis L, Magalhaes JG, Philpott DJ. Innate immune recognition at the epithelial barrier drive adaptive immunity: APCs take the back seat. Trends Immunol 2008; 29 (1): 41-49
82. Tanko MN, Manasseh AN, Echejoh GO. Relation between Helicobacter pylori, inflammatory (neutrophil) activity, chronic gastritis, gastric atrophy and intestinal metaplasia. Nigerian J Clin Pract 2008; 11 (3): 270-274
83. Robinson K, Kenefeck R, Pidgeon EL, et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 2008; 57: 1375-1385
84. Arnold 1С, Lee JY, Amieva MR, et al. Tolerance rather that immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology 2011; 140: 199-209
85. Kalali B, Mejias-Luque R, Javaheri A, Gerhard M.H. pylori virulence factors: influence on immune system and pathology. Mediators Inflamm 2014;2014: 426-435.

AttachmentSize
2016_01_019-026.pdf1.23 MB

No votes yet